Weisblum Eric 4
4 · Silo Pharma, Inc. · Filed May 27, 2025
Insider Transaction Report
Form 4
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
- Award
Options (right to buy)
2025-05-23+200,000→ 387,932 totalExercise: $0.43From: 2026-05-23Exp: 2035-05-23→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The options were issued pursuant to the Issuer's 2020 Omnibus Equity Incentive Plan and one hundred percent (100%) of the shares subject to the option shall vest on the one (1)-year anniversary of the date of grant.